Anticonceptivos orales combinados en el tratamiento de la dismenorrea asociada a endometriosis

Abstract

Dysmenorrhea related to endometriosis constitutes one of the main gynecological conditions worldwide. This complex disease, due to its ailments and chronic nature, becomes a very important medical, social and economic problem affecting 10 to 15% of women of reproductive age and 35% to 50% of women with pelvic pain and/or infertility. Since dysmenorrhea is the main complaint of the condition, therapy is focused on it, and combined oral contraceptives are currently one of the mainstays of treatment. The objective of the research was to consolidate updated scientific and clinical evidence on the action of combined oral contraceptives in dysmenorrhea associated with endometriosis, so a descriptive study of narrative type and literature review of scientific articles that provide evidence on combined oral contraceptives for dysmenorrhea associated with endometriosis period 2018-2022 was performed, including 14 articles from platforms such as PubMed, virtual health library (VHL) and Cochrane that describe the intervention of different combinations of oral contraceptives as treatment of endometriosis-related dysmenorrhea, decreasing the scores with the VAS pain scale. However, some comparative studies show that there are other options that surpass the efficacy of combined contraceptives, reporting better patient satisfaction. Finally, it was concluded that the use of combined oral contraceptives significantly reduces dysmenorrhea associated with endometriosis